Fibre-specific white matter reductions in Alzheimer's disease and mild cognitive impairment by Mito, Remika et al.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
King’s Research Portal 
 
DOI:
10.1093/brain/awx355
Document Version
Peer reviewed version
Link to publication record in King's Research Portal
Citation for published version (APA):
Mito, R., Raffelt, D., Dhollander, T., Vaughan, D. N., Tournier, J-D., Salvado, O., ... Connelly, A. (2018). Fibre-
specific white matter reductions in Alzheimer's disease and mild cognitive impairment. Brain : a journal of
neurology, 141(3), 888–902. https://doi.org/10.1093/brain/awx355
Citing this paper
Please note that where the full-text provided on King's Research Portal is the Author Accepted Manuscript or Post-Print version this may
differ from the final Published version. If citing, it is advised that you check and use the publisher's definitive version for pagination,
volume/issue, and date of publication details. And where the final published version is provided on the Research Portal, if citing you are
again advised to check the publisher's website for any subsequent corrections.
General rights
Copyright and moral rights for the publications made accessible in the Research Portal are retained by the authors and/or other copyright
owners and it is a condition of accessing publications that users recognize and abide by the legal requirements associated with these rights.
•Users may download and print one copy of any publication from the Research Portal for the purpose of private study or research.
•You may not further distribute the material or use it for any profit-making activity or commercial gain
•You may freely distribute the URL identifying the publication in the Research Portal
Take down policy
If you believe that this document breaches copyright please contact librarypure@kcl.ac.uk providing details, and we will remove access to
the work immediately and investigate your claim.
Download date: 05. Apr. 2019
 
 
Mito et al., Page 1 
Investigation of fibre-specific white matter reductions in Alzheimer’s 
disease and mild cognitive impairment 
 
Remika Mito
1,2
, David Raffelt
1
, Thijs Dhollander
1
, David N Vaughan
1,2,3
, J.-Donald 
Tournier
4,5
, Olivier Salvado
6
, Amy Brodtmann
1,2,7
, Christopher Rowe
8,9
, Victor L 
Villemagne
1,8,9
, Alan Connelly
1,2 
 
Author affiliations: 
1. Florey Institute of Neuroscience and Mental Health, Melbourne, Victoria, Australia 
2. Florey Department of Neuroscience and Mental Health, University of Melbourne, Melbourne, Victoria 
3. Department of Neurology, Austin Health, Victoria, Australia 
4. Department of Biomedical Engineering, Division of Imaging Sciences & Biomedical Engineering, King’s 
College London, London, UK 
5. Centre for the Developing Brain, King’s College London, London, UK 
6. CSIRO, Health & Biosecurity, The Australian eHealth Research Centre, Brisbane, Queensland, Australia 
7. Eastern Clinical Research Unit, Monash University, Box Hill Hospital, Melbourne, Victoria, Australia 
8. Department of Medicine, Austin Health, University of Melbourne, Victoria, Australia 
9. Department of Molecular Imaging & Therapy, Centre for PET, Austin Health, Heidelberg, Victoria, 
Australia 
 
Correspondence to: Remika Mito 
Postal address: Florey Institute of Neuroscience and Mental Health, 245 Burgundy Street, 
Heidelberg, Victoria 3084, Australia 
Email address: remika.mito@florey.edu.au  
 
Running title: Fibre-specific loss in Alzheimer’s disease 
 
 
This is a pre-copyedited, author-produced version of an article accepted for publication in 
Brain following peer review. The version of record 10.1093/brain/awx355 is available online 
at: https://academic.oup.com/brain/article-lookup/doi/10.1093/brain/awx355  
  
 
 
Mito et al., Page 2 
Abstract 
 
Alzheimer’s disease is increasingly considered a large-scale network disconnection 
syndrome, associated with progressive aggregation of pathological proteins, cortical atrophy, 
and functional disconnections between particular brain regions. These pathological changes 
are posited to arise in a stereotypical spatiotemporal manner, targeting intrinsic networks in 
the brain, most notably the default mode network. While this network-specific disruption has 
been thoroughly studied with functional neuroimaging, changes to specific white matter fibre 
pathways that underlie the brain’s structural networks have not been as closely investigated, 
largely due to the challenges of modelling complex white matter structure. Here, we applied a 
novel technique known as Fixel-Based Analysis to comprehensively investigate fibre tract-
specific differences at a within-voxel level (called “fixels”) in order to assess potential axonal 
loss in people with Alzheimer’s disease and mild cognitive impairment. We hypothesised that 
Alzheimer’s disease patients would exhibit extensive degeneration across key fibre pathways 
connecting default network nodes, while mild cognitive impairment patients would exhibit 
selective degeneration within fibre pathways connecting the medial temporal to orbitofrontal 
and posterior cingulate cortices; regions that exhibit the earliest functional disconnections in 
Alzheimer’s disease. Diffusion MRI data from Alzheimer’s disease (n=49), mild cognitive 
impairment (n=33), and healthy elderly control subjects (n=95) were obtained from the 
Australian Imaging, Biomarkers and Lifestyle study of ageing. We assessed microstructural 
differences in fibre density, and macrostructural differences in fibre bundle morphology using 
Fixel-Based Analysis. Whole-brain analysis was performed to compare groups across all 
white matter fixels. Subsequently, we performed a tract-of-interest analysis comparing fibre 
density and cross-section across 11 select white matter tracts, to investigate potentially subtle 
degeneration within fibre pathways in mild cognitive impairment, initially by clinical 
diagnosis alone, and then by including amyloid status (i.e., a positive or negative amyloid 
PET scan). Our whole-brain analysis revealed significant white matter loss manifesting both 
microstructurally and macrostructurally in Alzheimer’s disease patients, evident in specific 
fibre pathways associated with default mode network nodes. Reductions in fibre density and 
cross-section in mild cognitive impairment patients were only exhibited within the posterior 
cingulum and right uncinate fasciculus when statistical analyses were limited to tracts-of-
interest. Interestingly, these degenerative changes did not appear to be associated with high 
amyloid accumulation, given that amyloid-negative, but not positive, mild cognitive 
 
 
Mito et al., Page 3 
impairment subjects exhibited focal left posterior cingulum deficits. The findings of this 
study demonstrated a stereotypical distribution of white matter degeneration in patients with 
Alzheimer’s disease, which was in line with canonical findings from other imaging 
modalities, and with a network-based conceptualisation of the disease.  
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Introduction 
 
Historically, Alzheimer’s disease has been pathologically defined by the aggregation of 
abnormal amyloid-β and hyperphosphorylated tau proteins. The accumulation of amyloid-β 
has long been thought to play a precipitating role in disease pathogenesis, driving the 
pathological tau deposition and subsequent neurodegeneration that begins in the medial 
temporal lobe and later progresses throughout vulnerable neocortical regions (Hardy and 
Selkoe, 2002; Jack et al., 2010). This neurodegeneration, in turn, initially manifests as a 
primary amnestic syndrome, and later as widespread cognitive impairment as other domains 
are impaired by disease spread. However, PET imaging studies have shown that amyloid-β 
deposition commonly occurs in elderly people with normal cognition (Mintun et al., 2006; 
Aizenstein et al., 2008), while deposition patterns show no, or at best weak, correlations with 
clinical disease syndromes (Rabinovici et al., 2008; Rowe et al., 2010; Leyton et al., 2011; 
Rodrigue et al., 2012). Furthermore, therapeutic interventions that have focused upon 
reducing levels of amyloid-β to lessen their purported neurodegenerative effects have been 
largely ineffective (Castellani and Perry, 2012; Giacobini and Gold, 2013). 
 
While molecular pathologies are undoubtedly critical aspects of Alzheimer’s disease 
aetiology, a valuable way to view the disease and target therapeutic interventions may be to 
consider the global, network-based dysfunctions that are characteristic to the disease (Palop 
et al., 2006; Canter et al., 2016). Network-based theories of Alzheimer’s disease suggest that 
the disease selectively targets vulnerable regions and propagates across intrinsic networks in 
the brain, presumably via specific neuronal pathways (Frost and Diamond, 2010; Raj et al., 
2012; Zhou et al., 2012). Functional neuroimaging evidence has played a crucial role in 
supporting theories of network-level susceptibility, showing characteristic patterns of 
disconnection between functionally connected, but not necessarily spatial adjacent brain 
regions that make up so-called intrinsic connectivity networks. In particular, the default mode 
network (DMN) has been implicated in Alzheimer’s disease, and exhibits not only functional 
disconnection (Greicius et al., 2004; Buckner et al., 2009; Seeley et al., 2009; Zhou et al., 
2012), but also metabolic disruptions (Minoshima et al., 1997; Alexander et al., 2002; 
Drzezga et al., 2003; Nestor et al., 2003), atrophy (Pengas et al., 2010), and high amyloid-β 
accumulation (Buckner et al., 2005). Functional network disruptions are likely to be 
subserved by changes to white matter fibre pathways making up the brain’s structural 
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networks, and the co-occurrence of molecular, metabolic, and functional changes could be 
explained by the presence of structural connections and their subsequent disruption, 
propagating network-wide failures. Investigating alterations within specific white matter fibre 
pathways would thus likely provide greater understanding of network-based changes over the 
course of Alzheimer’s disease.  
 
To this end, diffusion-weighted imaging (DWI) is currently the only method available to non-
invasively study white matter fibre architecture in vivo, and has thus generated substantial 
interest, along with a rapidly increasing body of literature in its clinical applications. 
However, the value of DWI studies depends largely upon unbiased methods for data 
acquisition, pre- and post-processing of data, quantitative analysis, as well as careful 
interpretation of results (Jones et al., 2013). The vast majority of DWI studies investigating 
Alzheimer’s disease have analysed the DWI data based on the diffusion tensor model 
(diffusion tensor imaging (DTI)), and have performed quantitative comparisons using voxel-
averaged metrics derived from this model, such as fractional anisotropy and mean diffusivity, 
which purport to reflect the structural integrity of white matter.  
 
Over the past decade, numerous DTI studies have reported spatial and temporal changes in 
white matter that arise over the course of Alzheimer’s disease, the results of which are 
summarised in a number of extensive reviews (Chua et al., 2008; Sexton et al., 2011; Gold et 
al., 2012; Mak et al., 2016). Despite promising results revealing white matter abnormalities 
in Alzheimer’s disease, there are major shortcomings to DTI studies, which can render their 
findings to be both unreliable, and difficult to interpret biologically. A major limitation of the 
diffusion tensor is its limited ability to model complex and crossing fibre populations, which 
have been shown to be present in up to 90% of white matter voxels (Jeurissen et al., 2013). 
Accordingly, when differences are detected in white matter voxels containing crossing fibre 
populations, these are difficult to interpret or to assign to specific fibre pathways (Douaud et 
al., 2011; Gold et al., 2012; Jones et al., 2013b). As such, while the voxel-averaged measures 
of tensor-derived metrics are sensitive to abnormalities within certain regions of white matter, 
they are inherently not fibre-specific nor easily interpretable, particularly in crossing fibre 
voxels that constitute most of white matter. 
 
Higher-order DWI models have enabled estimation of multiple fibre orientations within 
voxels (Tournier et al., 2004, 2007; Assaf and Basser, 2005; Behrens et al., 2007). In order to 
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be sensitive to differences within specific fibre populations, it is important not only to 
estimate the orientations of each fibre population, but additionally to make use of quantitative 
metrics that independently characterise any degenerative changes to specific fibre populations 
within voxels. Doing so facilitates fibre tract-specific comparisons, as opposed to analyses of 
voxel-averaged metrics.  
 
A recent technique that enables fibre tract-specific statistical analysis is Fixel-Based Analysis 
(FBA) (Raffelt et al., 2017), whereby a “fixel” refers to a specific fibre population within a 
voxel (Raffelt et al., 2015). FBA is based on the analysis of DWI data using constrained 
spherical deconvolution (CSD) (Tournier et al., 2007), which enables characterisation of 
multiple fibre orientations within voxels. Using this approach, we can compare measures 
related to the total intra-axonal volume of white matter axons in any particular direction, thus 
providing a method that can be used to detect degeneration within specific white matter 
tracts. In a disease like Alzheimer’s, which is associated with substantial brain atrophy, it is 
important to account for the potential morphological changes that may contribute to observed 
differences in group comparisons, as well as within-voxel microstructural differences. To this 
end, FBA can be used to estimate: (i) differences in the density of fibres within a fibre 
bundle, (ii) differences in the fibre-bundle cross-section, or (iii) differences arising from a 
combination of both degenerative processes (see Figure 1) (Raffelt et al., 2017).  
 
In this cross-sectional study, we describe the first application of Fixel-Based Analysis to a 
cohort of participants clinically diagnosed with mild cognitive impairment (n = 33) and 
Alzheimer’s disease (n = 49). The aim of this study was to investigate if Alzheimer’s disease 
is indeed characterised by a stereotypical pattern of white matter degeneration, and if early 
signs of specific fibre tract degeneration are apparent in mild cognitive impairment patients, 
who represent a somewhat heterogeneous cohort at-risk for Alzheimer’s disease. We 
additionally investigated if early fibre tract degeneration differed between mild cognitive 
patients without amyloid-β accumulation to those with high amyloid-β accumulation, who 
likely represent a prodromal Alzheimer’s disease cohort. Our findings support theories of 
network-wide disruptions in Alzheimer’s disease, and exhibit the value of implementing a 
fibre-specific method to investigate white matter degeneration in vivo.   
 
Materials and Methods 
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Participants 
 
Participants included patients with clinical Alzheimer’s disease, mild cognitive impairment, 
and healthy elderly control subjects, all of whom were recruited as part of the Australian 
Imaging, Biomarkers and Lifestyle (AIBL) study of ageing. Alzheimer’s disease and mild 
cognitive impairment subjects were recruited from memory disorder clinics or by 
geriatricians, psychiatrists, and neurologists. Healthy control participants were recruited 
through community advertisement. All participants were classified into clinical groups 
according to AIBL criteria, as has been previously described (Ellis et al., 2009). In brief, all 
Alzheimer’s disease patients met National Institute of Neurological and Communicative 
Disorders and Stroke and Alzheimer’s Disease and Related Disorders Association (NINDS-
ADRDA) diagnostic criteria for probable Alzheimer’s disease, while mild cognitive 
impairment participants were classified by a clinical review panel as per internationally 
agreed criteria (Petersen et al., 1999; Winblad et al., 2004). Healthy control participants 
exhibited no cognitive impairment and satisfied inclusion and exclusion criteria detailed in 
Ellis et al. (2009). All participants also underwent an amyloid- PET scan with Carbon-11-
labelled Pittsburgh Compound B
 
(
11
C-PiB). Amyloid-β positivity was defined as previously 
described by Rowe et al. (2013), using a mean standardised uptake value ratio (SUVR) across 
the neocortex over a cut-off value of 1.4. Individuals were classified as amyloid-positive 
(SUVR ≥ 1.4) or negative (SUVR < 1.4). Participants with a clinical Alzheimer’s disease 
diagnosis, but who were amyloid-negative (n=3), were excluded from this study, while both 
amyloid-positive and negative mild cognitive impairment and healthy elderly control 
participants were included. The final cohort included 177 subjects: 95 healthy control 
subjects (31 amyloid-positive, and 64 negative), 33 subjects with mild cognitive impairment 
(20 amyloid-positive and 13 negative), and 49 Alzheimer’s disease subjects. A summary of 
clinical and demographic data is available in Table 1. All subjects provided informed written 
consent, and the study was approved by the ethics committee at Austin Health. 
 
Image acquisition and pre-processing 
 
MRI data were acquired using a 3T Siemens Tim Trio system (Siemens, Erlangen, Germany), 
with a 12-channel head coil receiver. Diffusion-weighted imaging was performed with the 
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following parameters: 60 axial slices, repetition time (TR)/echo time (TE) = 9200/112 ms, 
2.3 mm isotropic voxels, 128 x 128 acquisition matrix, acceleration factor = 2. Sixty 
diffusion-weighted images (b = 3000 s/mm
2
), and five volumes without diffusion weighting 
(b = 0 s/mm
2
), were obtained with echo planar imaging. The DWI acquisition time was 
approximately 9 minutes. A 3D MPRAGE (magnetization prepared rapid acquisition gradient 
echo) image (voxel size 1.2 x 1 x 1 mm, TR/TE = 2300/2.98, flip angle = 9°) was also 
obtained from each subject, and was used to compute intracranial volume using SPM8. 
 
Pre-processing of diffusion-weighted images included denoising of data (Veraart et al., 
2016), eddy-current correction and motion correction (Andersson and Sotiropoulos, 2016), 
bias field correction (Tustison et al., 2010), and up-sampling DWI spatial resolution by a 
factor of 2 in all three dimensions using cubic b-spline interpolation, to a voxel size of 1.15 
mm
3
 (Raffelt et al., 2012). Intensity normalisation across subjects was performed by deriving 
scale factors from the median intensity in select voxels of white matter, grey matter, and CSF 
in b=0 s/mm
2
 images, then applying these across each subject image. All pre-processing steps 
were conducted using commands either implemented within MRtrix3 (www.mrtrix.org), or 
using MRtrix3 scripts that interfaced with external software packages. 
 
Following these pre-processing steps, fibre orientation distributions (FODs) were computed 
using Single-Shell, 3-Tissue Constrained Spherical Deconvolution (SS3T-CSD), with group 
averaged response functions for white matter, grey matter, and CSF (Dhollander and 
Connelly, 2016; Dhollander et al., 2016). Spatial correspondence was achieved by first 
generating a group-specific population template with an iterative registration and averaging 
approach (Raffelt et al., 2011) using FOD images from 30 subjects (10 Alzheimer’s disease, 
10 mild cognitive impairment, and 10 healthy control subjects).  Each subject’s FOD image 
was then registered to the template via a FOD-guided non-linear registration (Raffelt et al., 
2011, 2012a?b?).  
 
A tractogram was generated using whole-brain probabilistic tractography on the population 
template. 20 million streamlines were first generated, and these were subsequently filtered to 
2 million streamlines using the SIFT algorithm (Smith et al., 2013) to reduce reconstruction 
biases. 
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Fixel-based metrics 
 
We derived metrics of apparent fibre density (FD), fibre-bundle cross-section (FC), and a 
combined measure of fibre density and cross-section (FDC) for each subject across all white 
matter fixels. Detailed methodology for fixel-based analysis, along with interpretations for 
fixel-based metrics have been described by Raffelt et al. (2017). These are summarised in 
brief below.  
 
Fibre density 
 
We used the Apparent Fibre Density framework to compute a measure related to the intra-
axonal restricted compartment at each fixel (Raffelt et al., 2012a?). According to this 
framework, a quantitative measure of FD can be derived from FOD images, given that the 
integral of the FOD along a particular direction is proportional to the intra-axonal volume of 
axons aligned in that direction. The FD measure is therefore specifically sensitive to 
alterations at a microstructural, within-voxel level (see Fig.1). The FD value was obtained by 
estimating each fixel’s contribution to the total DWI-signal in a voxel using SS3T-CSD 
(Dhollander and Connelly, 2016). Following spatial normalisation, the FD value for each 
fixel in each subject was then assigned to a fixel template mask. In this way, the FD metric in 
corresponding fixels could be compared across groups. 
 
Fibre bundle cross-section 
 
While FD enables estimation of differences in intra-axonal volume of a fibre pathway within 
a voxel, another likely scenario is that a loss of axons results in atrophy of a fibre bundle 
across its entire cross-section (see Fig.1). Atrophy of a fibre pathway could mean that the 
spatial extent occupied by that bundle decreases, resulting in a macrostructural, 
morphological change. The FC metric was computed to be sensitive to such a change, as 
described by Raffelt et al. (2017). Briefly, morphological differences in the fixel cross-
section (in the plane perpendicular to the fixel direction) were estimated for each fixel by 
using the non-linear warps to compute the change in FC required to spatially normalise the 
subject image to the template image. With respect to the template frame of reference, FC 
values larger than one indicate a larger fibre cross-section in the subject, while FC values 
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smaller than one indicate a smaller cross-section. 
 
Fibre density and cross-section 
 
Given that group differences may manifest as changes to both within-voxel fibre density and 
macrostructural changes in fibre-bundle cross-section (see Fig.1), we additionally computed a 
metric that combined both sources of information, namely the combined measure of fibre-
density and cross-section (FDC) (Raffelt et al., 2017). 
 
Voxel-based analysis of tensor-derived metrics 
 
The most common method to date to investigate changes in so-called measures of “white 
matter integrity” is using voxel-wise analyses of tensor-derived metrics, most commonly 
fractional anisotropy (FA) and mean diffusivity (MD). Therefore, in addition to the fibre 
tract-specific fixel-based metrics that constitute the primary results in the present work, we 
also performed voxel-based analysis of FA and MD measures derived from application of the 
tensor model to the same diffusion MRI data used for fixel-based analysis. The methodology 
is described in detail in Supplementary Material 1 (supplementary material is available at 
Brain online); however in brief, FA and MD were derived at each voxel per subject, and 
warped to the population template space using warps derived for fixel-based analysis. Voxel-
based analysis was then performed with threshold-free cluster enhancement (Smith and 
Nichols, 2009) to determine if there were any significant group differences in either FA or 
MD.  
 
Statistical analysis 
 
Whole-brain fixel-based analysis 
 
In order to identify regions with altered FD, FC, and FDC in the Alzheimer’s disease and 
mild cognitive impairment groups, we firstly compared metrics using whole-brain fixel-based 
analysis. Herein, we use the term ‘whole-brain fixel-based analysis’ or ‘whole-brain FBA’ to 
refer to a comparison of all white matter fixels identified within the brain. Statistical 
comparisons of FD, FC, and FDC between groups were performed at each white matter fixel 
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by a General Linear Model, comparing (1) Alzheimer’s disease versus controls, and (2) mild 
cognitive impairment versus controls. Age and intracranial volume were included as nuisance 
covariates. Connectivity-based smoothing and statistical inference was performed using 
connectivity-based fixel enhancement (CFE), using 2 million streamlines from the template 
tractogram, and with default smoothing parameters (smoothing = 10 mm full width half 
maximum, C=0.5, E=2, H=3) (Raffelt et al., 2015). Note that in CFE, smoothing is 
preferentially applied along structurally connected fixels, ensuring that fixel-based metrics 
are locally smoothed with fixels belonging to the same fibre tract. Family-wise error (FWE) 
corrected P-values were then assigned to each fixel using non-parametric permutation testing 
over 5000 permutations (Nichols and Holmes, 2002).  
 
Significant fixels (FWE-corrected P-value < 0.05) were then displayed using the mrview tool 
in MRtrix3. To better appreciate the fibre pathways implicated, significant fixels were 
displayed on the template-derived tractogram, in which streamlines were cropped to only 
those fixels that were significant. Significant streamlines were colour-coded either by 
streamline orientation (left-right: red, inferior-superior: blue, anterior-posterior: green), or by 
the effect size expressed as a percentage relative to the control group. Both whole-brain fixel-
based statistical analyses and visualisations were performed in MRtrix3. 
 
Tract-of-interest analysis 
 
We performed further tract-of-interest analyses to investigate potential degeneration of 
selective fibre pathways in mild cognitive impairment participants, who were potentially at 
risk of later developing Alzheimer’s disease. We selected all fixels that exhibited statistically 
significant decreases in the FDC metric in the Alzheimer’s disease group upon whole-brain 
FBA, and categorised these fixels into 11 white matter tracts, using anatomical diffusion 
tensor imaging (DTI) atlases to guide categorisation (Wakana et al., 2004; Mori et al., 2005; 
Oishi et al., 2009; Zhang et al., 2010). Mean FDC was computed across the fixels in each 
defined tract—namely, the bilateral uncinate fasciculi, inferior fronto-occipital fasciculi 
(IFOF), anterior cingulum and posterior cingulum, the genu and splenium of the corpus 
callosum, and left arcuate fasciculus—and compared across groups.  
 
Two tract-of-interest analyses were performed: firstly, comparing across the diagnostic 
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groups (Alzheimer’s disease and mild cognitive impairment, to healthy control subjects as 
per whole-brain FBA); and secondly, a follow-up analysis incorporating amyloid-β status to 
determine potential association of amyloid accumulation with white matter degeneration 
(Alzheimer’s disease (n = 49), amyloid-positive mild cognitive impairment (n = 20), 
amyloid-negative mild cognitive impairment (n = 13), and amyloid-positive healthy subjects 
(n = 31), compared to amyloid-negative healthy control subjects (n=64)). Statistical 
comparison was performed with a linear mixed model (with age, sex, and intracranial volume 
as covariates), using a Dunnett correction for multiple group comparisons in R software 
(multcomp package). A Bonferroni correction was performed for the 11 tracts (multiplying 
the P-value by a factor of 11). A significance threshold of 0.05 was used. Results were 
displayed as the mean FDC and 95% confidence interval for each group, as a percentage 
difference from the mean FDC of the control group. 
 
Results 
 
Clinical and demographic characteristics 
 
Clinical and demographic characteristics of each diagnostic group are summarised in Table 1. 
Patient and control groups did not significantly differ in age, sex, years of education or 
intracranial volume. Age histograms for each group are available in the supplementary 
material (Supplementary Fig. 1; available at Brain online).  
 
Whole-brain fixel-based analysis 
 
Figure 2 shows streamline segments associated with fixels that had a significant (FWE-
corrected P-value < 0.05) decrease in the Alzheimer’s disease group, for FD, FC, and FDC. 
Streamlines are coloured by the magnitude of reductions in Alzheimer’s disease patients 
compared to control subjects. Fibre pathways exhibited large decreases in microstructural 
fibre density, with some fibre pathways (such as the parahippocampal cingulum) exhibiting 
FD decreases of greater than 40% in Alzheimer’s disease patients compared to control 
subjects. Macrostructural decreases in fibre bundle cross-section were less pronounced, 
though more spatially extensive. While macrostructural FC and microstructural FD 
differences overlapped across some fibre tracts, macrostructural differences were more 
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apparent across long association fibres such as the cingulum bundle, superior and inferior 
longitudinal, and arcuate fasciculi, while commissural fibres and short association fibres, 
along with the IFOF, exhibited greater decreases in microscopic fibre density. Furthermore, 
some fibre pathways only exhibited decreases in FD, most notably the left fornix. When 
macro- and microstructural fibre differences were taken together using the FDC metric, the 
largest decreases in total intra-axonal volume occupied by fibre bundles were observed in 
posterior parietal white matter, the uncinate fasciculus, parahippocampal aspect of the 
cingulum bundle, and in the lateral aspects of the anterior commissure (Fig. 2). Figure 3 
displays in greater detail streamline segments with significant FDC decreases in Alzheimer’s 
disease patients. The 3D spatial distribution of affected fibre pathways for all three metrics 
can be appreciated in Supplementary Videos 1 and 2 (available at Brain online). As shown in 
Fig. 4, significant results within a voxel are specific to each fixel, even in crossing fibre 
regions. 
 
When mild cognitive impairment patients were compared to healthy controls with whole-
brain FBA, no significant decreases were observed across any fixels for any of the three 
metrics. 
 
Voxel-based analysis of tensor-derived metrics  
 
Alzheimer’s disease patients exhibited significant decreases in fractional anisotropy and 
significant increases in mean diffusivity across extensive white matter voxels, in line with 
previous reports (Supplementary Figure 2; available at Brain online). Additionally, 
significant FA increases were observed in Alzheimer’s disease patients compared to control 
subjects within voxels known to contain crossing fibre populations, in particular within the 
centrum semiovale (Figure 5).  
 
Tract-of-interest analysis 
 
Comparison of FDC between clinical diagnostic groups 
 
In the mild cognitive impairment group, significant decreases were apparent in the posterior 
cingulum bundle (left: t171 = -3.48, P = 0.001, right: t171 = -2.50, P = 0.026), and the right 
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uncinate fasciculus (t171 = -2.31, P = 0.043) only. Only the left posterior cingulum survived 
Bonferroni correction over the number of tracts investigated (corrected p-value = 0.014). No 
significant difference was found for the remainder of the tracts in the mild cognitive 
impairment group compared to controls (Fig. 6). Alzheimer’s disease patients exhibited 
decreased FDC in all 11 white matter tracts upon tract-of-interest analysis, when compared to 
the healthy controls, as expected given that the tracts-of-interest were defined in terms of 
already being significantly different upon whole-brain FBA. 
 
Association of FDC differences with amyloid positivity  
 
We further explored whether observed differences in mild cognitive impairment patients, as 
measured by decreases in FDC, were primarily in those individuals who also exhibited 
substantial amyloid-β accumulation. Comparing Alzheimer’s disease, amyloid-positive mild 
cognitive impairment, amyloid-negative mild cognitive impairment, and amyloid-positive 
healthy subjects to amyloid-negative control subjects, we found significant decreases in FDC 
in the left posterior cingulum in the amyloid-negative mild cognitive impairment group only 
(t169 = -2.82, P = 0.02), however this did not survive Bonferroni correction. Figure 7 shows 
that the this group exhibited a trend toward lower FDC than the amyloid-positive mild 
cognitive impairment group across most of the remaining fibre pathways; however, this was 
not significant. No significant differences were found between amyloid-positive and negative 
healthy control subjects (Fig. 7). All 11 white matter tracts exhibited a significant decrease in 
tract-of-interest-based FDC in the Alzheimer’s disease group compared to healthy control 
subjects without high amyloid accumulation, which is as expected given how these tracts-of-
interest were defined.  
 
 
Discussion 
 
In the present study, we applied a recently established method to investigate fibre tract-
specific white matter changes in Alzheimer’s disease and mild cognitive impairment. This 
comprehensive investigation of pathway-specific disruptions offers valuable findings 
pertaining both to Alzheimer’s disease specifically, and to the investigation of white matter 
structural networks more broadly. The major disease-related findings of this study were that: 
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(1) Alzheimer’s disease patients exhibit extensive axonal loss within specific fibre pathways, 
in line with network-based conceptualisations of the disease; and (2) mild cognitive 
impairment patients exhibit subtle axonal reduction within the posterior cingulum, which 
does not appear to be associated with high amyloid- accumulation.  
 
Extensive axonal loss across characteristic fibre pathways in Alzheimer’s disease 
 
Application of novel fixel-based methodology to a cohort of Alzheimer’s disease patients 
enabled the identification of substantial fibre density and cross-sectional reductions within 
specific white matter structures. Fibre tract-specific atrophy (as indexed by the FC metric) 
was spatially extensive in Alzheimer’s disease patients; however, greater effects were 
observed in microstructural fibre density (FD) reduction, suggesting substantial axonal loss at 
a microstructural level in the presence of morphological alterations to white matter structures 
in Alzheimer’s disease. 
 
Our results exhibited selective degeneration of a number of fibre pathways in Alzheimer’s 
disease patients; in particular, the cingulum bundle along its anterior, posterior and 
parahippocampal aspects, the corpus callosum (splenium and genu), uncinate fasciculus, 
inferior fronto-occipital fasciculus, and arcuate fasciculus. These fibre pathways connect 
brain regions that have previously been functionally implicated in Alzheimer’s disease, and 
thus, our findings provide support for a structural basis to theories of network-based 
degeneration.  
 
In line with the functional neuroimaging literature, which suggests that network degeneration 
occurs selectively within intrinsic connectivity networks, particularly the default mode 
network (Delbeuck et al., 2003; Palop et al., 2006; Zhou et al., 2012; Brier et al., 2014; Jones 
et al., 2016), the white matter fibre pathways exhibiting fibre density and cross-sectional 
decreases in this cohort included those that likely form reciprocal connections between DMN 
regions. For example, the cingulum bundle is understood to form connections with and 
between the anterior medial prefrontal cortex, posterior cingulate cortex, and medial temporal 
lobe (Greicius et al., 2009; Jones et al., 2013a). Additionally, structural disruption of the 
uncinate fasciculus would be consistent with functional disconnections within the ventral 
DMN, namely between the ventral medial prefrontal cortex and hippocampal formation. 
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Disconnections within the genu of the corpus callosum could reflect the observed functional 
disruptions between the anterior medial prefrontal cortex bilaterally, while the splenium 
likely contributes homotopic connections between the posterior inferior parietal cortices, as 
well as the posterior cingulate and retrosplenial cortices (De Lacoste et al., 1985; Teipel et 
al., 2010).  
 
Some fibre pathways that exhibited differences in Alzheimer’s disease patients, such as the 
inferior fronto-occipital fasciculus, are not typically thought to connect to DMN regions that 
are functionally affected in the disease. However, recent studies do suggest that the IFOF 
constitutes more extensive connections than previously thought, including connections to the 
angular gyrus (Hau et al., 2016). Degeneration to this fibre pathway has also been previously 
reported in Alzheimer’s disease (Agosta et al., 2012; Bosch et al., 2012), although it may be 
more closely related to vascular pathology and white matter hyperintensities than to 
functional disconnections (Taylor et al., 2017).  
 
The fibre tracts implicated in this present study were also largely congruent with the regions 
of white matter abnormalities reported in the extensive body of DTI literature (Rose et al., 
2000; Zhang et al., 2007; Chua et al., 2008; Nakata et al., 2008; Villain et al., 2008; 
Damoiseaux et al., 2009; Acosta-Cabronero et al., 2010; Sexton et al., 2011). Moreover, our 
whole-brain voxel-based analyses of tensor-derived metrics were similarly in line with 
previous studies, with similar regions of white matter exhibiting decreased FA and increased 
MD. However, it is important to highlight in this context that while the fixel-based results in 
this study overlap to some extent with regions identified in DTI findings both in the present 
study and in previous work, the fixel-based findings offer much greater anatomical specificity 
and biological interpretability by identifying tract-specific differences and accounting for the 
substantial atrophic changes that arise in the disease.  
 
Notably, the pathways affected in Alzheimer’s disease patients were mostly long association 
fibres traversing between distant brain regions, which cross with other fibre pathways at 
many points along their length. This has precluded robust interpretation of DTI findings, as 
the orientation of underlying fibres cannot be reliably estimated using the diffusion tensor 
model. DTI metrics are inherently voxel-averaged, with the potential to be highly misleading 
in crossing fibre regions (Jones et al., 2013). Indeed, previous studies have reported 
potentially misleading findings of increased anisotropy in disease cohorts in regions with 
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crossing fibres, for example in the centrum semiovale (Douaud et al., 2011) and along the 
cingulum bundle (Lee et al., 2015). Similarly, here we observed regions of increased FA in 
Alzheimer’s disease; in particular, within the centrum semiovale exhibiting increased FA 
(Fig. 5), while FDC decreases within fixels belonging to the superior longitudinal fasciculus 
were observed within this same region.  
 
Tensor-based metrics are sensitive to diffusional properties that are averaged across a voxel, 
and thus the above-mentioned increases in FA in the centrum semiovale can be explained by 
the relative preservation of the corticospinal tract and corpus callosum, in the presence of 
degeneration of the superior longitudinal fasciculus. As illustrated in Figure 5C, by modelling 
the underlying fibre structure using a fibre orientation distribution (FOD) function derived 
from constrained spherical deconvolution, we can directly assess differences within specific 
fixels, even within crossing-fibre regions. In contrast, the tensor is sensitive at best to the 
voxel-averaged differences, which can potentially result in a highly misleading conclusion.  
 
Subtle degeneration of the posterior cingulum in mild cognitive impairment 
 
The posterior cingulate cortex has been implicated as a region affected early in the course of 
Alzheimer’s disease, exhibiting hypometabolism (Minoshima et al., 1997; Nestor et al., 
2003), and functional disruption (Greicius et al., 2004; Zhou et al., 2012), even in 
presymptomatic individuals who later go on to develop the clinical syndrome. The posterior 
aspect of the cingulum bundle likely constitutes short association fibres connecting regions of 
the posterior cingulate along with those that connect to structures of the temporal lobe (Jones 
et al., 2013a; Wu et al., 2016). Accordingly, our primary tract-of-interest analysis exhibited 
selective disruption within the left posterior cingulum in mild cognitive impairment patients. 
Large decreases were also observed in the right posterior cingulum and uncinate fasciculus; 
however, these were not significant following multiple comparison correction over the 
number of fibre bundles investigated. This finding would suggest that clinical mild cognitive 
impairment is associated with selective degeneration within fibre pathways that are later 
implicated in Alzheimer’s disease. Indeed, our findings are consistent with previous DTI 
studies, which have similarly indicated early changes within the posterior cingulum in the 
progression of Alzheimer’s disease (Fellgiebel et al., 2005; Zhang et al., 2007; Nakata et al., 
2008; Villain et al., 2008). 
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It is important to note, however, that mild cognitive impairment is a clinical label, and the 
underlying pathology, as well as the clinical trajectory, can be heterogeneous (Petersen et al., 
1999; Larrieu et al., 2002; Jicha et al., 2006). While mild cognitive impairment subjects are 
at higher risk of progressing to Alzheimer’s disease than cognitively unimpaired elderly 
individuals (Petersen, 2004; Gauthier et al., 2006; Mitchell and Shiri-Feshki, 2009), only 
those mild cognitive impairment subjects who also exhibit a high amyloid-β accumulation are 
believed to represent a prodromal Alzheimer’s disease cohort (Villemagne et al., 2013).   
 
Contrary to expectation, we found that the observed decrease in FDC in the left posterior 
cingulum in mild cognitive impairment patients was driven to a greater extent by those 
without high amyloid-β accumulation. Subtle degeneration to the left posterior cingulum was 
observed (significant only at an uncorrected level) in the mild cognitive impairment group 
without high amyloid-β accumulation, whereas mild cognitive impairment patients with high 
amyloid-β accumulation did not exhibit significant abnormalities in any of the investigated 
white matter tracts when compared to healthy elderly subjects without high amyloid-β 
accumulation.  
 
Though a subtle result, this was seemingly contradictory to previous suggestions of the 
posterior cingulum as a critical pathway in Alzheimer’s disease pathogenesis. Indeed, the 
posterior cingulum has been theorised to play an important role in early disease, connecting 
the amyloid-laden posterior cingulate cortex with the entorhinal and hippocampal regions, 
within which previously benign neurofibrillary changes are converted into an accelerated, 
degenerative tauopathy (Acosta-Cabronero et al., 2010). Specific abnormalities within this 
fibre tract have also been suggested as a potential early predictor for the development of 
Alzheimer’s disease (Zhang et al., 2007; Nakata et al., 2008). However, the subtle posterior 
cingulum degeneration exhibited by the amyloid--negative mild cognitive impairment 
group in our study may be more closely associated to other pathological insults, such as white 
matter hyperintensities of presumed vascular aetiology, than to amyloid-β accumulation 
(Wardlaw et al., 2013). These lesions were not accounted for in the present study, and future 
work would benefit from investigating the effects of other pathological insults in this 
pathologically heterogeneous clinical group.  
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Technical advantages of fixel-based analysis 
 
The investigation of white matter degeneration in Alzheimer’s disease and mild cognitive 
impairment is by no means a recent development (Brun and Englund, 1986; Englund et al., 
1988). Diffusion tensor imaging was a pioneering method that enabled investigation of 
microstructural changes to white matter in vivo, and was rapidly adopted as a potentially 
powerful method to investigate abnormalities in diseased individuals (Pierpaoli and Basser, 
1996; Rose et al., 2000; Taoka et al., 2006). DTI studies have identified regions of purported 
microstructural abnormality, being highly sensitive to the diffusional properties of white 
matter. Voxel-based results of DTI studies have been extrapolated to suggest the likely fibre 
structures that may be implicated in Alzheimer’s disease; however, the inherently voxel-
based nature of these analyses precludes the ability to identify specific fibre pathways. 
Moreover, as has been demonstrated with our voxel-based FA analysis, there are, limitations 
to using a voxel-based method when investigating complex white matter microstructure, 
which can result in misleading findings.  
 
The most popular approach to perform diffusion tensor analyses is with Tract-Based Spatial 
Statistics (TBSS; Smith et al., 2006). This method was developed to improve correspondence 
of FA images, and circumvent partial volume effects by projecting volumetric data onto a 
white matter ‘skeleton’, and was described to be “tract-based”. However, the skeletonisation 
and projection step discards orientational information from the diffusion data, and the method 
is not in fact “tract-based” in reality. Moreover, there are major shortcomings to TBSS that 
have been described previously, and the results of TBSS analyses are often thought to be less 
biologically plausible and have decreased detection accuracy when compared to whole-brain 
voxel-based analyses (Jones et al., 2013b; Bach et al., 2014; Schwarz et al., 2014; Raffelt et 
al., 2015). With the advent of higher-order diffusion models, more recent studies have 
adopted novel tractographic approaches or crossing fibre models to improve sensitivity to 
white matter changes in a more fibre tract-specific manner, when performing voxel-based 
comparisons (Reijmer et al., 2012; Wang et al., 2016; Doan et al., 2017). The major 
advantage to the present study however, is moving entirely beyond a tensor model that has 
inherently voxel-averaged comparisons, to using a fibre tract-specific model and performing 
fixel-based comparison that provide more directly interpretable measures of structural 
connectivity. 
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Fixel-based analysis not only accounts for crossing fibre populations, but additionally 
accounts for the differing ways in which changes to intra-axonal volume may manifest 
(Raffelt et al., 2017). Accounting for both microstructural changes in density (with the FD 
metric), and macrostructural, morphometric changes (with the FC metric) enables a more 
comprehensive analysis of total intra-axonal volume changes within a fibre pathway (FDC 
metric) (Raffelt et al., 2017). Indeed, in a disease like Alzheimer’s, in which substantial white 
matter loss occurs (Brun and Englund, 1986), partial volume effects could contribute to 
significant findings in voxel-based analyses of white matter microstructure. As such, it is 
important to consider both microstructural and morphological differences that might reflect 
axonal loss.  
 
Fixel-based analysis enables a more comprehensive insight into white matter changes, with 
recent application in other disease states (Raffelt et al., 2017; Vaughan et al., 2017; Wright et 
al., 2017; Genc et al., 2017). Here, we report the first application to an Alzheimer’s disease 
and mild cognitive impairment cohort, which has offered novel perspectives into the 
degenerative changes to fibre pathways in both these clinical disease states.  
 
Limitations and future directions 
 
Despite these technical advantages, there are a number of limitations to our study. The cross-
sectional study design limited our ability to describe white matter degenerative changes over 
the progression of mild cognitive impairment and Alzheimer’s disease. Future studies 
investigating the longitudinal trajectory of mild cognitive impairment patients who progress 
to Alzheimer’s disease is likely to provide further insight into the association of clinical 
trajectory with degenerative changes in particular fibre pathways. 
 
Furthermore, in this study we did not exclude participants with other pathological insults that 
could potentially influence white matter degeneration, in conjunction with the molecular 
neuropathological processes of Alzheimer’s disease. In particular, white matter 
hyperintensities on MRI were apparent in many of the patients as well as healthy control 
subjects in our cohort, similar to previously reported cohorts (Yoshita et al., 2006; Brickman, 
2013; Thal et al., 2014). The presence of these lesions has been associated with differences in 
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tensor-derived metrics (Vernooij et al., 2008; Altamura et al., 2016), and is also likely to be 
associated with decreases in fixel-wise FD (Dhollander et al., 2017). Future work will thus 
investigate the association of fibre density and cross-sectional differences with the presence 
of connected lesions.  
 
While the diffusion imaging data acquired in our study were of high quality (particularly with 
regard to gradient directions and b-value), a limitation of our data is that reverse-phase 
encoded images were not available for all our subjects, and as such, we could not perform 
EPI distortion correction. The absence of such correction could introduce greater variance in 
the fixel-based metrics, which could result in more conservative estimates of differences 
between groups.   
 
One of the major unanswered questions regarding Alzheimer's disease is the means by which 
the various potential pathological insults that characterize the disease might contribute to its 
clinical and pathological progression. While the focus of the present work was to investigate 
tract-specific white matter connectivity differences in Alzheimer’s disease and mild cognitive 
impairment, further research is undoubtedly necessary to provide insight into the association 
between white matter degeneration and other disease hallmarks. To this end, Fixel-Based 
Analysis, in conjunction with other neuroimaging methods, could enable much more fibre 
tract-specific insight than has previously been possible. Future work should thus probe the 
fixel-based changes within fibre structures connecting regions of pathological injury detected 
by other imaging modalities, be they microvascular insults, neurofibrillary pathology, or grey 
matter atrophy.  
 
Conclusion 
 
Our findings suggest that Alzheimer’s disease patients exhibit a characteristic pattern of fibre 
tract degeneration, which manifests both as microstructural and macrostructural reductions in 
white matter. The pattern of reductions in structural connectivity is consistent with functional 
disconnections reported in previous literature, and our findings provide support of a structural 
basis to network disconnection theories. However, the extent to which white matter 
degeneration is related to amyloid-β pathology is unclear, and our findings in mild cognitive 
impairment patients suggest that degeneration may be more closely associated with clinical 
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symptomatology than to abnormal accumulation of amyloid-β. In order to build a more 
comprehensive understanding of the pathogenic mechanisms and the association between 
various pathological insults in Alzheimer’s disease, future work incorporating fixel-based 
analysis is likely to be highly insightful. 
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Supplementary material 
 
Supplementary Material 1: Methodological steps for investigating fractional anisotropy 
Voxel-based analysis of fractional anisotropy (FA) was performed across groups for 
comparative reasons in this study. All steps were performed using MRtrix3 commands, and 
steps were performed on the same preprocessed images used for fixel-based analysis. Firstly, 
the diffusion tensor was derived for each subject’s preprocessed DW image, which estimates 
the tensor using an iteratively re-weighted, linear least squares estimator (Veraart et al., 
2013). An FA map was subsequently generated in each subject’s space to compute the FA of 
the diffusion tensors. Each individual subject’s FA map was then transformed to the 
population template space, by using the subject-to-template warp generated during the FOD 
registration step for fixel-based analysis. Voxel-wise statistical analysis could then be 
performed in template space, to compare FA across groups. Voxel-based analysis was 
performed using threshold-free cluster enhancement with default parameters (dh = 0.1, E = 
0.5, H = 2) (Smith and Nichols, 2009), and both increases and decreases in FA were tested 
for between groups. Significant decreases and increases in FA could then be visualised.  
 
Supplementary Figure 1: Age histograms by group. Age distribution is shown for the 
Alzheimer’s disease (AD), healthy elderly control, and mild cognitive impairment (MCI) 
groups. Mean age for each group is displayed as a dotted line. 
 
Supplementary Figure 2: Voxel-wise fractional anisotropy decreases and mean 
diffusivity increases in Alzheimer’s disease patients compared to healthy control 
subjects. Voxel-based analyse of fractional anisotropy and mean diffusivity were performed, 
comparing Alzheimer’s disease patients to healthy control subjects. Voxels with (A) a 
significant decrease in fractional anisotropy, or (B) a significant increase in mean diffusivity 
are shown across a single coronal, axial, and sagittal slice, coloured by family-wise error 
(FWE) corrected p-value.  
 
Supplementary Video 1: Fibre pathways exhibiting significant reductions in 
Alzheimer’s disease compared to healthy control subjects from whole-brain Fixel-Based 
Analysis.  
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Significant fixels (family wise error-corrected p-value < 0.05) are projected onto a tractogram 
to display significant streamlines. Streamlines are coloured by direction (anterior-posterior: 
green; superior-inferior: blue; left-right: red). Significant results for the fibre density (FD), 
fibre cross-section (FC), and fibre density and cross-section (FDC) are displayed (left to 
right) and projected onto the population template.  
 
Supplementary Video 2: Effect size maps displaying significant reductions in 
Alzheimer’s disease patients compared to healthy control subjects from whole-brain 
Fixel-Based Analysis. As per Supplementary Video 1, significant fixels are projected onto a 
tractogram to display streamlines with significant decreases in fixel-specific metrics in the 
Alzheimer’s disease group. Streamlines are coloured by percentage decrease in the 
Alzheimer’s disease group compared to the healthy control subjects, as per the scale bar 
shown on the right. Significant results are shown for each of the three metrics: fibre density 
(FD), fibre cross-section (FC), and fibre density and cross-section (FDC).  
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Tables 
 
Table 1: Clinical and demographic data of participants 
 HC 
n = 95 
MCI 
n = 33 
AD 
n = 49 
Statistic 
Age, years (SD) 78.3 (7.5) 79.4 (7.6) 77.4 (8.2) F = 0.68 
P = 0.51 
Males (%) 45 (47.4) 16 (48.5) 22 (44.9) χ
2 
= 0.12 
P = 0.94 
11
C-PIB 
positivity (%) 
31 (32.6) 20 (60.6) 49 (100
1
) χ2 = 60.0 
P < 0.001 
ICV (SD) 1432.6 (134.4) 1420.5 (158.6) 1403.0 (137.0) F = 0.76 
P = 0.47 
Years of 
education (SD) 
15.0 (9.5) 13.0 (3.7) 12.8 (3.7) F = 1.87 
P = 0.16 
CDR (SD) 0 (0.1) 0.5 (0.3) 1.3 (0.7) F = 103.0 
P < 0.001 
MMSE (SD) 28.6 (1.4) 26.6 (2.4) 18.2 (7.3) F = 55.4 
P < 0.001 
 
Data are presented as mean (SD) or number (%). Reported P-values from one-way between-
groups ANOVA for age and intracranial volume, and chi-square test for independence for sex 
and 
11
C-PIB positivity. AD = Alzheimer’s disease patients. CDR = clinical dementia rating. 
11
C-PIB = Carbon-11 labelled Pittsburgh Compound B. HC = healthy elderly control 
subjects.  ICV = intracranial volume (cm
3
). MCI = mild cognitive impairment patients. 
MMSE = mini mental state examination. 
1
Note that 
11
C-PIB positivity was an inclusion 
criterion for the AD group. 
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Figures 
 
Figure 1: Fixel-based metrics. The schematic represents a fibre bundle cross-section (grey 
circles represent axons, while the grid represents imaging voxels). A change to the intra-
axonal volume may manifest as: (a) difference in tissue microstructure that result in a change 
in within-voxel fibre density; (b) a macroscopic difference in a fibre bundle’s cross-section; 
or (c) difference in a combination of both fibre density and bundle cross-sectional area. 
Figure republished with permission of Neuroimage, from Investigating white matter fibre 
density and morphology using fixel-based analysis (Raffelt et al. 2017; 144: 58–73); 
permission conveyed through Copyright Clearance Centre, Inc. 
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Figure 2: Fibre pathways exhibiting significant differences in Alzheimer’s disease from 
whole-brain Fixel-Based Analysis. Significant fixels (FWE-corrected p-value < 0.05) were 
cropped from the template tractogram to include only streamline points that correspond to 
significant fixels. Streamlines were coloured by percentage effect decrease in the Alzheimer’s 
disease group compared to the healthy control group for FD, FC, and FDC. Significant 
streamlines are displayed across axial slices of the population template map.  
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Figure 3: Fibre pathways exhibiting significant FDC decreases in Alzheimer’s disease 
patients compared to healthy control subjects. Streamline segments were cropped from the 
template tractogram to include only those corresponding to fixels that exhibited a significant 
(FWE-corrected p-value < 0.05) decrease in the FDC metric in the Alzheimer’s disease 
group. Significant streamline points are shown across a number of axial slices, and are 
coloured by direction (anterior-posterior: green; superior-inferior: blue; left-right: red). 
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Figure 4: Fixel-based analysis enables fibre tract-specific analysis in crossing fibre 
regions. Fixels that were significantly decreased in the Alzheimer’s disease group compared 
to the healthy control group for the FDC metric are shown for a single sagittal slice (location 
shown on coronal section on bottom right). The zoomed insets exhibits differences to specific 
fixels in crossing fibre regions, with fixels coloured by family wise error-corrected p-value.  
 
 
 
Mito et al., Page 45 
Figure 5: Significant voxel-wise increases in fractional anisotropy in Alzheimer’s disease 
compared to healthy controls. Panel A shows voxels exhibiting a significant (FWE-
corrected p-value < 0.05) increase in FA in the Alzheimer’s disease group compared to 
healthy controls along coronal, axial and sagittal views. As shown in Panel B, the centrum 
semiovale contains fibre structures belonging to the corticospinal tract, superior longitudinal 
fasciculus, and corpus callosum, as can be demonstrated with probabilistic tractography. 
Panel B: Alzheimer’s disease patients exhibit white matter degeneration specifically within 
the superior longitudinal fasciculus, with relative preservation of the corticospinal tract and 
body of the corpus callosum. Using a DTI model, this difference would be detected as an 
increase in FA, given that the relative contribution of the superior longitudinal fasciculus to 
the tensor is decreased, resulting in a misleading increase in anisotropy along the direction of 
the corticospinal tract. Modelling the equivalent voxel with a fibre orientation distribution 
function (FOD) derived using constrained spherical deconvolution (CSD), we can 
appropriately resolve the different fibre orientations within the voxel. Thus, we can detect a 
fixel-specific decrease in the fixel corresponding to the superior longitudinal fasciculus, 
without any significant decrease in fixels belonging to the corticospinal tract and corpus 
callosum in the same voxel.  
 
 
 
Mito et al., Page 46 
 
Figure 6: Significant tracts in mild cognitive impairment from tract-of-interest analysis 
comparing diagnostic groups. Left panel: Mean fibre density and cross-section (diamonds) 
and 95% confidence intervals (bars) within tracts-of-interest are displayed for Alzheimer’s 
disease (AD) and mild cognitive impairment (MCI) groups, as a percentage difference from 
the healthy control mean, adjusted for age, sex, and intracranial volume. Significant tracts 
(p<0.05) are displayed in colour, while non-significant are shown in grey. Results at the top 
(above dotted line) correspond to tracts where mild cognitive impairment patients was 
significantly different from healthy controls. Right panel: Tracts are shown in glass brain 
representations. Top brain shows tracts that were significantly altered in the mild cognitive 
impairment group, while bottom brain shows all tracts included in analysis, which all showed 
significant decrease in Alzheimer’s disease patients. Tracts are coloured to correspond with 
the left panel. Note that tracts were selected from significant fixels in the Alzheimer’s disease 
group from the whole-brain FBA. IFOF = inferior fronto-occipital fasciculus. CC = corpus 
callosum.  
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Figure 7: Group differences in mean FDC when including amyloid-β status. Left panel: 
Mean FDC (diamonds) and 95% confidence intervals (bars) within tracts of interest are 
displayed for four groups: Alzheimer’s disease (AD), amyloid-negative mild cognitive 
impairment (MCI-), amyloid-positive mild cognitive impairment (MCI+), and amyloid-
positive healthy subjects (HC+). These are represented as a percentage difference from the 
control group; in this case, amyloid-negative healthy subjects (HC-). The left posterior 
cingulum was significantly decreased in the MCI- group. Right panel: Top glass brain shows 
the left posterior cingulum (green), which was significantly decreased in the MCI- group. 
Bottom glass brain shows all tracts, coloured according to the left panel, as per Figure 6. 
 
